Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis von Singh, Ajay K, Carroll, Kevin, Perkovic, Vlado, Solomon, Scott, Jha, Vivekanand, Johansen, Kirsten L, Lopes, Renato D, Macdougall, Iain C, Obrador, Gregorio T, Waikar, Sushrut S, Wanner, Christoph, Wheeler, David C, Więcek, Andrzej, Blackorby, Allison, Cizman, Borut, Cobitz, Alexander R, Davies, Rich, Dole, Jo, Kler, Lata, Meadowcroft, Amy M, Zhu, Xinyi, McMurray, John J.V

Volltext

Cardiovascular Event Rates Among Hemodialysis Patients Across Geographical Regions—A Snapshot From The Dialysis Outcomes and Practice Patterns Study (DOPPS) von Stirnadel-Farrant, Heide A., Karaboyas, Angelo, Cizman, Borut, Bieber, Brian A., Kler, Lata, Jones, Delyth, Cobitz, Alexander R., Robinson, Bruce M.

Volltext

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease von Stirnadel-Farrant, Heide A, Luo, Jiacong, Kler, Lata, Cizman, Borut, Jones, Delyth, Brunelli, Steven M, Cobitz, Alexander R

Volltext

Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis von Singh, Ajay K, Carroll, Kevin, McMurray, John J.V, Solomon, Scott, Jha, Vivekanand, Johansen, Kirsten L, Lopes, Renato D, Macdougall, Iain C, Obrador, Gregorio T, Waikar, Sushrut S, Wanner, Christoph, Wheeler, David C, Więcek, Andrzej, Blackorby, Allison, Cizman, Borut, Cobitz, Alexander R, Davies, Rich, DiMino, Tara L, Kler, Lata, Meadowcroft, Amy M, Taft, Lin, Perkovic, Vlado

Volltext

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial von Singh, Ajay K, Blackorby, Allison, Cizman, Borut, Carroll, Kevin, Cobitz, Alexander R, Davies, Rich, Jha, Vivekanand, Johansen, Kirsten L, Lopes, Renato D, Kler, Lata, Macdougall, Iain C, McMurray, John J V, Meadowcroft, Amy M, Obrador, Gregorio T, Perkovic, Vlado, Solomon, Scott, Wanner, Christoph, Waikar, Sushrut S, Wheeler, David C, Wiecek, Andrzej

Volltext

SP340ANEMIA AND MORTALITY IN PATIENTS WITH NONDIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE von Stirnadel-Farrant, Heide, Luo, Jiacong, Kler, Lata, Cizman, Borut, Jones, Delyth, Brunelli, Steven, Cobitz, Alexander

Volltext

The ASCEND-ND trial: study design and participant characteristics von Perkovic, Vlado, Blackorby, Allison, Cizman, Borut, Carroll, Kevin, Cobitz, Alexander R, Davies, Rich, DiMino, Tara L, Jha, Vivekanand, Johansen, Kirsten L, Lopes, Renato D, Kler, Lata, Macdougall, Iain C, McMurray, John J V, Meadowcroft, Amy M, Obrador, Gregorio T, Solomon, Scott, Taft, Lin, Wanner, Christoph, Waikar, Sushrut S, Wheeler, David C, Wiecek, Andrzej, Singh, Ajay K

Volltext

ASCEND Program: Efficacy and Safety from ASCEND-D and -ND and Overall MACE Finding: FR-OR66 von Singh, Ajay K., Carroll, Kevin, Perkovic, Vlado, Solomon, Scott D., Jha, Vivekanand, Johansen, Kirsten L., Lopes, Renato D., Macdougall, Iain C., Obrador, Gregorio T., Waikar, Sushrut S., Wanner, Christoph, Wheeler, David C., Wiecek, Andrzej, Blackorby, Allison, Cizman, Borut, Cobitz, Alexander R., Davies, Rich, Dimino, Tara L., Dole, Jo F., Kler, Lata, Meadowcroft, Amy M., Taft, Lin, Zhu, Xinyi, McMurray, John

Volltext

MO559ASCEND-ND: STUDY DESIGN AND BASELINE CHARACTERISTICS von Perkovic, Vlado, Blackorby, Allison, Cizman, Borut, Carroll, Kevin, Cobitz, Alexander, Davies, Richard, DiMino, Tara, Jha, Vivekanand, Johansen, Kirsten, Lopes, Renato, Kler, Lata, Macdougall, Iain, McMurray, John, Meadowcroft, Amy, Obrador, Gregorio, Solomon, Scott, Taft, Lin, Wanner, Christoph, Waikar, Sushrut S, Wheeler, David, Wiecek, Andrzej Jan, Singh, Ajay

Volltext

GI262570, a Tyrosine-Based PPAR[Gamma] Agonist, Reduces Triglycerides and Increases HDL-C Concentrations in Patients with Type 2 Diabetes Mellitus When Combined with Glibenclamide... von EDWARDS, ROBERT C, KLER, LATA, MCNEIL, SIMON J, ROUND, PATRICK

Volltext

GI262570, a Non-Thiazolidinedione PPAR[Gamma] Agonist, Improves MetaboLic Control in Patients with Type 2 Diabetes Mellitus When Combined with Glibenclamide Treatment von RAZ, I, KLER, LATA, EDWARDS, ROBERT C, MCNEIL, SIMON J

Volltext

GI262570, a tyrosine-based PPARγ agonist, reduces triglycerides and increases HDL-C concentrations in patients with type 2 diabetes mellitus when combined with glibenclamide treatm... von Kler, Lata, Edwards, Robert C., McNeil, Simon J., Round, Patrick

Volltext

Additional file 2: of Anemia and mortality in patients with nondialysis-dependent chronic kidney disease von Stirnadel-Farrant, Heide, Jiacong Luo, Kler, Lata, Cizman, Borut, Jones, Delyth, Brunelli, Steven, Cobitz, Alexander

Volltext bestellen

The Safety of Ranitidine Bismuth Citrate in Controlled Clinical Studies von Pipkin, Graham A., Mills, Jane G., Kler, Lata, Dixon, Jonathon S., Wood, John R.

Volltext